Craig-Hallum Maintains Buy on Neuraxis, Raises Price Target to $13

Craig-Hallum analyst Chase Knickerbocker has maintained a 'Buy' rating on Neuraxis (AMEX: NRXS) and increased the price target from $8 to $13. This adjustment reflects a positive outlook for the company's stock performance.